The National Institute for Health and Clinical Excellence has updated its website to include Quick References Guides (QRGs) for the recently published fracture prevention guidance.
The QRGs are now available for Primary Prevention and Secondary Prevention. These QRGs provide a summary of the advice for preventing fragility fractures in post-menopausal women. Alendronate is the initial recommendation in both guidelines with alternative agents being recommended in individuals who cannot take alendronate and who meet more stringent treatment criteria.
Action: Clinicians will fine these summary guidelines more accessible than the full clinical guidelines.
|« NICE rimonabant advice withdrawn||Generic statins and QOF targets »|